Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MRNA |
---|---|---|
09:32 ET | 45375 | 152.34 |
09:34 ET | 30698 | 153.689 |
09:36 ET | 53815 | 155.81 |
09:38 ET | 36444 | 155.9487 |
09:39 ET | 39240 | 154.8 |
09:41 ET | 22664 | 154.41 |
09:43 ET | 14360 | 155.17 |
09:45 ET | 37935 | 154.09 |
09:48 ET | 21329 | 153.69 |
09:50 ET | 9584 | 152.755 |
09:52 ET | 7920 | 152.42 |
09:54 ET | 15541 | 153.6005 |
09:56 ET | 14070 | 153.22 |
09:57 ET | 16628 | 153.7129 |
09:59 ET | 11538 | 153.54 |
10:01 ET | 6816 | 153.41 |
10:03 ET | 13825 | 152.2981 |
10:06 ET | 15948 | 151.589 |
10:08 ET | 12357 | 150.9251 |
10:10 ET | 14702 | 151.495 |
10:12 ET | 8783 | 151.55 |
10:14 ET | 8738 | 152 |
10:15 ET | 12116 | 152.105 |
10:17 ET | 7103 | 152.73 |
10:19 ET | 8850 | 153.31 |
10:21 ET | 4656 | 153.57 |
10:24 ET | 12756 | 154.15 |
10:26 ET | 12610 | 153.7999 |
10:28 ET | 15282 | 153.13 |
10:30 ET | 3502 | 153.1 |
10:32 ET | 4146 | 152.88 |
10:33 ET | 6467 | 153.43 |
10:35 ET | 5881 | 154.1781 |
10:37 ET | 11038 | 154.2196 |
10:39 ET | 8740 | 154.2605 |
10:42 ET | 15725 | 154.49 |
10:44 ET | 20816 | 153.46 |
10:46 ET | 4288 | 153.835 |
10:48 ET | 7529 | 153.43 |
10:50 ET | 9975 | 153.15 |
10:51 ET | 30141 | 154.1 |
10:53 ET | 14987 | 154.78 |
10:55 ET | 35820 | 155 |
10:57 ET | 26452 | 155.065 |
11:00 ET | 11544 | 154.789 |
11:02 ET | 219513 | 155.63 |
11:04 ET | 41196 | 153.64 |
11:06 ET | 125960 | 151.65 |
11:08 ET | 48441 | 150.655 |
11:09 ET | 53968 | 150.505 |
11:11 ET | 67917 | 149.465 |
11:13 ET | 46602 | 149.865 |
11:15 ET | 107460 | 146.78 |
11:18 ET | 54510 | 146.575 |
11:20 ET | 55123 | 146.49 |
11:22 ET | 53445 | 146.44 |
11:24 ET | 13955 | 146.3644 |
11:26 ET | 15582 | 147.22 |
11:27 ET | 31175 | 147.52 |
11:29 ET | 19145 | 147.29 |
11:31 ET | 8734 | 147.455 |
11:33 ET | 23164 | 147.3101 |
11:36 ET | 12558 | 147.03 |
11:38 ET | 13666 | 146.9 |
11:40 ET | 22979 | 146.315 |
11:42 ET | 7869 | 146.375 |
11:44 ET | 36860 | 146.02 |
11:45 ET | 25023 | 145.99 |
11:47 ET | 11593 | 145.945 |
11:49 ET | 24965 | 145.85 |
11:51 ET | 10758 | 145.6805 |
11:54 ET | 14498 | 145.13 |
11:56 ET | 27843 | 144.775 |
11:58 ET | 15044 | 144.78 |
12:00 ET | 17803 | 144.303 |
12:02 ET | 15499 | 144.37 |
12:03 ET | 15410 | 144.18 |
12:05 ET | 76602 | 143.6 |
12:07 ET | 12666 | 143.995 |
12:09 ET | 33188 | 143.98 |
12:12 ET | 13471 | 143.82 |
12:14 ET | 20102 | 142.89 |
12:16 ET | 12181 | 143 |
12:18 ET | 13132 | 142.5101 |
12:20 ET | 28687 | 143.17 |
12:21 ET | 31608 | 142.41 |
12:23 ET | 15537 | 142.43 |
12:25 ET | 35316 | 143 |
12:27 ET | 19357 | 142.87 |
12:30 ET | 26381 | 142.57 |
12:32 ET | 30180 | 142.145 |
12:34 ET | 25932 | 141.73 |
12:36 ET | 12898 | 142.08 |
12:38 ET | 13458 | 142.12 |
12:39 ET | 22409 | 142.345 |
12:41 ET | 33504 | 141.7 |
12:43 ET | 5341 | 141.93 |
12:45 ET | 4360 | 141.8216 |
12:48 ET | 13979 | 141.815 |
12:50 ET | 7869 | 142.195 |
12:52 ET | 7990 | 142.49 |
12:54 ET | 7984 | 142.5 |
12:56 ET | 23696 | 141.66 |
12:57 ET | 7971 | 141.6 |
12:59 ET | 12540 | 141.5599 |
01:01 ET | 4516 | 141.645 |
01:03 ET | 9307 | 141.5054 |
01:06 ET | 16817 | 141.11 |
01:08 ET | 20658 | 140.88 |
01:10 ET | 19229 | 141.08 |
01:12 ET | 17501 | 141.8521 |
01:14 ET | 20065 | 141.59 |
01:15 ET | 13285 | 142.03 |
01:17 ET | 10348 | 141.6799 |
01:19 ET | 4335 | 141.685 |
01:21 ET | 5310 | 141.855 |
01:24 ET | 13428 | 142.14 |
01:26 ET | 8438 | 141.7 |
01:28 ET | 11261 | 141.915 |
01:30 ET | 9319 | 141.78 |
01:32 ET | 3380 | 141.6 |
01:33 ET | 11533 | 141.88 |
01:35 ET | 5354 | 141.61 |
01:37 ET | 7977 | 141.914 |
01:39 ET | 6916 | 141.93 |
01:42 ET | 4006 | 141.99 |
01:44 ET | 19755 | 142.18 |
01:46 ET | 12014 | 142.2125 |
01:48 ET | 4370 | 141.99 |
01:50 ET | 8653 | 141.955 |
01:51 ET | 11885 | 142.4 |
01:53 ET | 10859 | 141.84 |
01:55 ET | 9083 | 141.68 |
01:57 ET | 4184 | 141.63 |
02:00 ET | 5609 | 141.62 |
02:02 ET | 9210 | 141.78 |
02:04 ET | 3729 | 141.76 |
02:06 ET | 9304 | 141.565 |
02:08 ET | 3274 | 141.89 |
02:09 ET | 5420 | 141.88 |
02:11 ET | 5627 | 141.51 |
02:13 ET | 6009 | 141.81 |
02:15 ET | 13341 | 141.84 |
02:18 ET | 10587 | 142.05 |
02:20 ET | 7794 | 142.175 |
02:22 ET | 15733 | 141.83 |
02:24 ET | 39036 | 141.38 |
02:26 ET | 12608 | 141.36 |
02:27 ET | 9239 | 141.31 |
02:29 ET | 2601 | 141.33 |
02:31 ET | 20238 | 141.51 |
02:33 ET | 9545 | 141.36 |
02:36 ET | 10069 | 141.29 |
02:38 ET | 15232 | 141.7 |
02:40 ET | 17790 | 141.5 |
02:42 ET | 23090 | 141.425 |
02:44 ET | 18180 | 141.996 |
02:45 ET | 9605 | 141.9692 |
02:47 ET | 22439 | 141.9199 |
02:49 ET | 11678 | 141.52 |
02:51 ET | 7742 | 141.48 |
02:54 ET | 13294 | 141.41 |
02:56 ET | 8862 | 141.3073 |
02:58 ET | 12080 | 141.285 |
03:00 ET | 24372 | 141.075 |
03:02 ET | 27691 | 141.465 |
03:03 ET | 7715 | 141.15 |
03:05 ET | 8860 | 141.005 |
03:07 ET | 9123 | 141.27 |
03:09 ET | 14186 | 141.505 |
03:12 ET | 16386 | 141.52 |
03:14 ET | 8670 | 141.63 |
03:16 ET | 19516 | 141.42 |
03:18 ET | 13284 | 141.65 |
03:20 ET | 13189 | 141.88 |
03:21 ET | 28082 | 141.525 |
03:23 ET | 16299 | 141.89 |
03:25 ET | 12798 | 141.79 |
03:27 ET | 12280 | 141.78 |
03:30 ET | 21774 | 141.39 |
03:32 ET | 18359 | 141.3901 |
03:34 ET | 22355 | 142.09 |
03:36 ET | 11384 | 142.4351 |
03:38 ET | 23526 | 142.455 |
03:39 ET | 22075 | 142.535 |
03:41 ET | 47547 | 142.6 |
03:43 ET | 18181 | 142.37 |
03:45 ET | 27757 | 142.62 |
03:48 ET | 59293 | 142.405 |
03:50 ET | 27889 | 142.51 |
03:52 ET | 82063 | 142.445 |
03:54 ET | 41363 | 142.585 |
03:56 ET | 88027 | 141.635 |
03:57 ET | 75717 | 142.34 |
03:59 ET | 84652 | 142.55 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Moderna Inc | 54.6B | -9.1x | --- |
ICON PLC | 26.9B | 39.4x | +4.68% |
Biogen Inc | 32.8B | 28.1x | -18.14% |
Biontech SE | 23.9B | 195.1x | --- |
Grifols SA | 6.2B | 73.3x | --- |
Charles River Laboratories International Inc | 10.7B | 24.5x | +15.57% |
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. Its diverse development pipeline consists of 45 therapeutic and vaccine programs, nine of which are in late-stage development. Its products include COVID-19 vaccines (mRNA-1273/Spikevax, next-generation mRNA-1283), RSV vaccine (mRNA-1345), Seasonal influenza vaccines (mRNA-1010, mRNA-1011, mRNA-1012, mRNA-1020 and mRNA-1030), Combination vaccines (mRNA-1083, mRNA-1230, mRNA-1045 and mRNA-1365), CMV vaccine (mRNA-1647), EBV vaccine (mRNA-1189 and mRNA-1195) and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $54.6B |
---|---|
Revenue (TTM) | $5.2B |
Shares Outstanding | 383.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.54 |
EPS | $-15.66 |
Book Value | $36.27 |
P/E Ratio | -9.1x |
Price/Sales (TTM) | 10.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -99.73% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.